• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Proxy Advisory Firm Glass Lewis Recommends Ventas Shareholders Vote "FOR ALL" of Ventas's Highly Qualified Directors

    4/20/22 10:13:00 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate
    Get the next $VTR alert in real time by email

    Recommends that Shareholders Support the Company's "Say on Pay" Proposal

    Shareholders Urged to Vote "FOR ALL" of Ventas's Directors and "FOR" the Company's Executive Compensation Program on the WHITE Proxy Card

    Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), an independent proxy advisory firm, has recommended that shareholders vote "FOR ALL" of Ventas's 11 experienced directors on the WHITE proxy card in advance of the upcoming Annual Meeting of Stockholders ("Annual Meeting") to be held on April 27, 2022.

    Both leading proxy advisory firms, Glass Lewis and Institutional Shareholder Services, have now recommended shareholders reject Land & Buildings' proxy campaign, in which it is seeking to force the removal of Ventas's Presiding Director from the Company's Board.

    In commenting on Ventas's highly qualified Board, multiyear refreshment process and its determination that support for Land & Buildings is not warranted, Glass Lewis noted1:

    • "When comparing the experience and qualifications of the two opposing director nominees, we believe Mr. Shelton's executive and operational experience in the healthcare sector – including at hospitals and medical office buildings, which comprise a large portion of Ventas' portfolio – remains a critical asset for Ventas as it emerges from the pandemic and navigates ongoing challenges in the operational and macro environment. Therefore, we do not consider it to be in the best interests of Ventas shareholders to elect Mr. Litt at the cost of displacing Mr. Shelton from the board."
    • "Since 2019, the board has appointed four new directors, including Mr. Embler this year, and since 2018, two longer-tenured directors have retired, including Mr. Gellert this year. We note the Company's refreshment process has also resulted in enhanced diversity of directors not only in terms of race and gender but also thought and perspective."
    • "The board's appointment of Mr. Embler, who has significant experience as an institutional investor, including in the REIT space, and who has served on several public company boards, including a REIT, should help to ensure that improving investor relations is a top priority in the boardroom. While L&B protests Mr. Embler's appointment as a defensive move to block Mr. Litt's candidacy, in our view, Mr. Embler is objectively the better candidate for the Ventas board at this time, given the Company's circumstances and the board's needs and stated criteria for new directors."
    • "The Ventas board has not been sitting on its hands and, in our view, appears to be taking appropriate action to address identified concerns. In addition to the board refreshment that began in 2018, Ventas appointed new leadership in its senior housing business at the start of 2020, just before the pandemic took hold. This led to strategic changes such as diversifying the operators that Ventas partners with to run its senior housing properties."

    In commenting on Ventas's superior returns, forward-thinking capital allocation decisions and high-quality diversified portfolio of real estate, Glass Lewis noted:

    • "We note Ventas' current year-to-date TSR figure, now 14 trading days later, stands at 19.5%, but that's still best among the index. Likely more encouraging for Ventas shareholders, we note the Company's trailing 1-year TSR of 15% is significantly better than the average negative return of -5% among the other NAREIT Health Care Index constituents. Further, Ventas has delivered a TSR of 97% over the last two years, since April 14, 2020, which was in the midst of the COVID-19 crisis and market volatility, exceeding all peers including Welltower's 94% over that period, which reflects the post-pandemic recovery in senior housing currently underway. Lastly, we would also note Ventas' trailing 3-year TSR has been marginally better than the peer average."
    • "In our view, L&B's stated concerns regarding stale leadership, capital allocation missteps, and senior housing business strategy and performance do not resonate. As the Company points out, L&B's statement that Ventas owns a superior and better positioned portfolio of assets would seem to directly contradict L&B's assertion that Ventas has deployed capital poorly."
    • "On the other hand, however, we believe the Dissident has failed to present compelling evidence that the Ventas board has overseen poor capital allocation decisions or that the Company's SHOP performance or actual FFO per share growth has been materially worse than Welltower in recent years. To the contrary, as discussed above, Ventas appears to have a superior, well-positioned portfolio as a result of forward-thinking capital allocation decisions, adjusted its SHOP operator strategy well before the Dissident's campaign and has generated broadly similar (if not better) performance as Welltower before, during and after the pandemic."

    In commenting on its recommendation that shareholders vote in favor of the Company's executive compensation program and the changes the Board has made in response to shareholder feedback, Glass Lewis noted:

    • "We note, however, that NEO retention awards were granted prior to the annual meeting in 2021, and following the meeting and shareholder feedback, the Company implemented a series of compensation quantum reductions for fiscal 2021 and 2022, including a reduction in 2022 target executive compensation, which we view as positive steps."
    • "This positive trajectory is reinforced in certain changes to incentives for 2022, namely: a return to a more formulaic short-term incentive plan, ESG metrics for short and long-term incentives (as initiated in fiscal 2021), and a heavier emphasis on TSR metrics under the long-term incentive plan, which may help re-align the executive and shareholder experience."

    Commenting on the Glass Lewis report, Ventas issued the following statement:

    Ventas is pleased that the two leading proxy advisory firms have recommended that shareholders support the Company's 11 director nominees, and that Glass Lewis recommends shareholders support the Company's executive compensation program. Ventas appreciates the thoughtful feedback of its shareholders and believes it is taking the right steps to extend its track record of outperformance. With the strong oversight of its Board, Ventas has prudently managed through the challenges of the COVID-19 pandemic and driven solid growth and shareholder returns, while ensuring the safety of its operators and employees. The Company believes it is well-positioned to capture the upside of the ongoing COVID recovery in the senior housing space to deliver further value creation.

    Ventas shareholders are reminded that their vote is extremely important, no matter how many or how few shares they own. The Company advises all shareholders to simply discard any Blue proxy card received from Land & Buildings. Instead, to follow the Board's recommendation, shareholders should use the WHITE proxy card to vote "FOR ALL" of the Company's highly qualified directors and vote "FOR" the approval, on an advisory basis, of the Company's executive compensation program.

    If you have questions about how to vote your shares or need additional copies of the proxy materials, please call the firm assisting us with the solicitation of proxies:

     

    INNISFREE M&A INCORPORATED

     

    Shareholders may call toll free:

    (877) 750-9496

     

    Banks & Brokers may call collect:

    (212) 750-5833

    About Ventas

    Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries – healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada, and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, research & innovation properties; medical office & outpatient facilities, hospitals and other healthcare real estate. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.

    Cautionary Statements

    This communication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among others, statements of expectations, beliefs, future plans and strategies, anticipated results from operations and developments and other matters that are not historical facts. Forward-looking statements include, among other things, statements regarding our and our officers' intent, belief or expectation as identified by the use of words such as "may," "will," "project," "expect," "believe," "intend," "anticipate," "seek," "target," "forecast," "plan," "potential," "opportunity," "estimate," "could," "would," "should" and other comparable and derivative terms or the negatives thereof.

    Forward-looking statements are based on management's beliefs as well as on a number of assumptions concerning future events. You should not put undue reliance on these forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements. We do not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made. You are urged to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance in our filings with the Securities and Exchange Commission ("SEC"), including those made in the "Summary Risk Factors" section, "Risk Factors" section and "Management's Discussion and Analysis of Financial Condition and Results of Operations" section of our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

    Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) the impact of the ongoing COVID-19 pandemic and its extended consequences, including of the Delta, Omicron or any other variant, on our revenue, level of profitability, liquidity and overall risk exposure and the implementation and impact of regulations related to the CARES Act and other stimulus legislation and any future COVID-19 relief measures; (b) our ability to achieve the anticipated benefits and synergies from, and effectively integrate, our acquisitions and investments, including our acquisition of New Senior Investment Group Inc.; (c) our exposure and the exposure of our tenants, managers and borrowers to complex healthcare and other regulation and the challenges and expense associated with complying with such regulation; (d) the potential for significant general and commercial claims, legal actions, regulatory proceedings or enforcement actions that could subject us or our tenants, managers or borrowers to increased operating costs and uninsured liabilities; (e) the impact of market and general economic conditions, including economic and financial market events, inflation, change in interest rates, supply chain pressures, events that affect consumer confidence, our occupancy rates and resident fee revenues, and the actual and perceived state of the real estate markets, labor markets and public capital markets; (f) our ability, and the ability of our tenants, managers and borrowers, to navigate the trends impacting our or their businesses and the industries in which we or they operate; (g) the risk of bankruptcy, insolvency or financial deterioration of our tenants, managers borrowers, and other obligors and our ability to foreclose successfully on the collateral securing our loans and other investments in the event of a borrower default; (h) our ability to identify and consummate future investments in or dispositions of healthcare assets and effectively manage our portfolio opportunities and our investments in co-investment vehicles, joint ventures and minority interests; (i) risks related to development, redevelopment and construction projects; (j) our ability to attract and retain talented employees; (k) the limitations and significant requirements imposed upon our business as a result of our status as a REIT and the adverse consequences (including the possible loss of our status as a REIT) that would result if we are not able to comply; (l) the risk of changes in healthcare law or regulation or in tax laws, guidance and interpretations, particularly as applied to REITs, that could adversely affect us or our tenants, managers or borrowers; (m) increases in our borrowing costs as a result of becoming more leveraged or as a result of changes in interest rates and phasing out of LIBOR rates; (n) our reliance on third parties to operate a majority of our assets and our limited control and influence over such operations and results; (o) our dependency on a limited number of tenants and managers for a significant portion of our revenues and operating income; (p) the adequacy of insurance coverage provided by our policies and policies maintained by our tenants, managers or other counterparties; (q) the occurrence of cyber incidents that could disrupt our operations, result in the loss of confidential information or damage our business relationships and reputation; (r) the impact of merger, acquisition and investment activity in the healthcare industry or otherwise affecting our tenants, managers or borrowers; and (s) the risk of catastrophic or extreme weather and other natural events and the physical effects of climate change.

    Important Additional Information Regarding Proxy Solicitation

    The Company has filed a definitive proxy statement (the "Proxy Statement") and form of associated WHITE proxy card with the SEC in connection with the solicitation of proxies for the Company's 2022 annual meeting of stockholders (the "2022 Annual Meeting"). The Company, its directors and certain of its executive officers will be participants in the solicitation of proxies from stockholders in respect of the 2022 Annual Meeting. Information regarding the names of the Company's directors and executive officers and their respective interests in the Company by security holdings or otherwise is set forth in the Proxy Statement. To the extent holdings of such participants in the Company's securities have changed since the amounts described in the Proxy Statement, such changes have been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC. Details concerning the nominees of the Company's Board of Directors for election at the 2022 Annual Meeting are included in the Proxy Statement. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS OF THE COMPANY ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH OR FURNISHED TO THE SEC, INCLUDING THE COMPANY'S DEFINITIVE PROXY STATEMENT AND ANY AMENDMENTS AND SUPPLEMENTS THERETO AND ACCOMPANYING WHITE PROXY CARD WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and stockholders will be able to obtain a copy of the definitive proxy statement and other relevant documents filed by the Company free of charge from the SEC's website at http://www.sec.gov and at the Company's investor relations website at https://ir.ventasreit.com.

     


    1 Permission to use quotations neither sought nor obtained

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220420005707/en/

    Get the next $VTR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VTR

    DatePrice TargetRatingAnalyst
    3/7/2025Hold → Buy
    Argus
    1/17/2025$66.00 → $65.00Neutral → Outperform
    Robert W. Baird
    10/1/2024$61.00 → $71.00Equal Weight → Overweight
    Wells Fargo
    3/18/2024$50.00In-line → Outperform
    Evercore ISI
    2/26/2024$52.00 → $46.00Overweight → Equal Weight
    Wells Fargo
    1/30/2024$60.00Buy
    Deutsche Bank
    1/16/2024$48.00 → $53.00Neutral → Buy
    BofA Securities
    11/7/2023$44.00 → $51.00Neutral → Outperform
    Wedbush
    More analyst ratings

    $VTR
    Financials

    Live finance-specific insights

    See more
    • Ventas Reports 2025 First Quarter Results

      Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today reported results for the first quarter ended March 31, 2025. CEO Remarks "Ventas delivered a strong first quarter of 2025, as we executed on our strategy to capitalize on the unprecedented multiyear growth opportunity in senior housing. We drove double-digit growth in our senior housing operating portfolio (SHOP), which powered our first quarter results," said Debra A. Cafaro, Ventas Chairman and CEO. "Already this year, we have completed nearly all of our original billion-dollar investment guidance in attractive SHOP investments designed to increase our forward enterprise growth rate. Our investment pipeline continues to grow and

      4/30/25 4:10:00 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ventas Announces First Quarter 2025 Earnings Release Date and Conference Call

      Ventas, Inc. (NYSE:VTR) will issue its first quarter 2025 earnings release after the close of trading on the New York Stock Exchange on Wednesday, April 30, 2025. A conference call to discuss those earnings will be held on Thursday, May 1, 2025 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com. A telephonic replay will be available at (800) 770-2030 (or +1 (609) 800-9909 for international callers), passcode 7655497, after the earnings call and will

      4/4/25 4:18:00 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ventas Reports 2024 Full Year Results, Provides 2025 Outlook and Increases Dividend

      Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today reported results for the full year and fourth quarter ended December 31, 2024. CEO Remarks "Ventas delivered strong financial performance and growth in the fourth quarter and full year 2024 as we executed on our strategy to capture the unprecedented multiyear growth opportunity in senior housing. Our team delivered the third consecutive year of double-digit growth in our senior housing operating portfolio (SHOP) and completed over two billion dollars of accretive investments focused on senior housing that enhance our growth profile," said Debra A. Cafaro, Ventas Chairman and CEO. "We expect compelling demand for senior housing

      2/12/25 4:10:00 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate

    $VTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Ventas Inc.

      SC 13G - Ventas, Inc. (0000740260) (Subject)

      10/15/24 1:39:07 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Ventas Inc. (Amendment)

      SC 13G/A - Ventas, Inc. (0000740260) (Subject)

      2/13/24 5:16:09 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G filed by Ventas Inc.

      SC 13G - Ventas, Inc. (0000740260) (Subject)

      2/9/24 10:05:20 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate

    $VTR
    SEC Filings

    See more
    • SEC Form 144 filed by Ventas Inc.

      144 - Ventas, Inc. (0000740260) (Subject)

      5/2/25 5:02:17 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 10-Q filed by Ventas Inc.

      10-Q - Ventas, Inc. (0000740260) (Filer)

      5/1/25 4:27:33 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ventas Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Ventas, Inc. (0000740260) (Filer)

      4/30/25 4:33:57 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate

    $VTR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Ventas Reports 2025 First Quarter Results

      Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today reported results for the first quarter ended March 31, 2025. CEO Remarks "Ventas delivered a strong first quarter of 2025, as we executed on our strategy to capitalize on the unprecedented multiyear growth opportunity in senior housing. We drove double-digit growth in our senior housing operating portfolio (SHOP), which powered our first quarter results," said Debra A. Cafaro, Ventas Chairman and CEO. "Already this year, we have completed nearly all of our original billion-dollar investment guidance in attractive SHOP investments designed to increase our forward enterprise growth rate. Our investment pipeline continues to grow and

      4/30/25 4:10:00 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Land & Buildings Sends Letter to National Health Investors Stockholders and Files Definitive Proxy Materials Detailing Urgent Need for Boardroom Change

      Outlines Current Board's Serious Conflicts of Interest Regarding Ongoing Lease Renewal Negotiations With Major Tenant National Healthcare Corp (NHC) Details How NHI's Archaic Corporate Governance, Interlocked Board and Lack of True Independence Have Directly Led to Underperformance Believes Land & Buildings' Independent Candidates – Adam Troso and Jim Hoffmann – Possess the REIT Expertise and Qualifications to Maximize Stockholder Value and Help Realize NHI's True Potential Urges NHI Stockholders to Vote FOR Land & Buildings' Two Highly Qualified Nominees on the GOLD Proxy Card Today, Land & Buildings Investment Management, LLC (together with its affiliates, "Land & Buildings"), a signi

      4/9/25 4:05:00 PM ET
      $NHI
      $VTR
      $WELL
      Real Estate Investment Trusts
      Real Estate
    • Ventas Announces First Quarter 2025 Earnings Release Date and Conference Call

      Ventas, Inc. (NYSE:VTR) will issue its first quarter 2025 earnings release after the close of trading on the New York Stock Exchange on Wednesday, April 30, 2025. A conference call to discuss those earnings will be held on Thursday, May 1, 2025 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com. A telephonic replay will be available at (800) 770-2030 (or +1 (609) 800-9909 for international callers), passcode 7655497, after the earnings call and will

      4/4/25 4:18:00 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate

    $VTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Ventas upgraded by Argus

      Argus upgraded Ventas from Hold to Buy

      3/7/25 8:20:28 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ventas upgraded by Robert W. Baird with a new price target

      Robert W. Baird upgraded Ventas from Neutral to Outperform and set a new price target of $65.00 from $66.00 previously

      1/17/25 7:52:13 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ventas upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Ventas from Equal Weight to Overweight and set a new price target of $71.00 from $61.00 previously

      10/1/24 7:53:59 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate

    $VTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chairman and CEO Cafaro Debra A exercised 10,322 shares at a strike of $65.45 and sold $682,135 worth of shares (10,322 units at $66.09) (SEC Form 4)

      4 - Ventas, Inc. (0000740260) (Issuer)

      5/5/25 6:02:31 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Director Smith Maurice S was granted 107 shares, increasing direct ownership by 0.46% to 23,198 units (SEC Form 4)

      4 - Ventas, Inc. (0000740260) (Issuer)

      4/18/25 2:50:38 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Director Roy Sumit was granted 99 shares, increasing direct ownership by 0.58% to 17,263 units (SEC Form 4)

      4 - Ventas, Inc. (0000740260) (Issuer)

      4/18/25 2:50:31 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate

    $VTR
    Leadership Updates

    Live Leadership Updates

    See more
    • Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

      Believes NHI is Significantly Undervalued with Opportunities to Unlock its Valuable Assets, Including Upcoming Lease Renewal with Tenant National Healthcare Corporation Highlights Poor Corporate Governance and Serious Conflicts of Interest Among Board Members Expresses Serious Concerns that NHI Board Cannot Fairly Represent Both Landlord and Tenant in Lease Renegotiation Given Substantial Economic and Personal Ties to NHC Discloses Likely Substantial Upside to Lease Rental Rates if Lease is Negotiated at Arms-Length Believes Shareholders Need to Send a Clear Message at Upcoming Annual Meeting – Ahead of Critical Lease Renegotiations – that Maintaining the Status Quo is Not an Option

      4/18/24 9:15:00 AM ET
      $NHC
      $NHI
      $SUI
      $VTR
      Hospital/Nursing Management
      Health Care
      Real Estate Investment Trusts
      Real Estate
    • Ventas Appoints Theodore Bigman and Joe V. Rodriguez, Jr. to Board of Directors

      Enters Into Cooperation Agreement with Land & Buildings Ventas, Inc. (NYSE:VTR) today announced that its Board of Directors has appointed Theodore Bigman and Joe V. Rodriguez, Jr. to the Board, effective immediately. In connection with the appointments, which align with Ventas's ongoing focus on Board refreshment and maintaining strong governance, the Company has entered into a mutual cooperation agreement (the "Cooperation Agreement") with shareholder Land & Buildings Investment Management LLC ("Land & Buildings"). Mr. Bigman brings significant investing and capital markets experience, and has served as a private investor and as founder and Chief Investment Officer of Bigman Holdings,

      3/4/24 8:03:00 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ardent Announces Senior Leadership Appointments and Promotions

      Ardent Health Services today announced the appointment of two new senior operations leaders and the promotion of three executives to expanded roles. Mike Matthews has been appointed president of Ardent Physician Services. He will oversee Ardent's medical group operations across eight markets in six states while working closely with providers to create greater alignment across the continuum of care. Matthews was previously senior vice president at ScionHealth where he led the company's physician enterprise, which included more than 500 providers across 13 states. Prior to that, he served as regional vice president of physician services for Lifepoint Health. David Schultz has been named p

      4/12/23 10:00:00 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate